Barnes Alane P's Form 4 filing
Biocryst Pharmaceuticals Inc (BCRX) · filed Dec 23, 2025
- Accession no.
- 0000882796-25-000043
- Filed
- Dec 23, 2025
- Trade date
- Dec 19-22, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $166.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barnes Alane PCIK 0001584348 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | FTax withholdingDisposed | −16,902 | $7.41 | −$125,243.82 | 420,524 | Direct | |
| Dec 22, 2025 | Common Stock | SSaleDisposed | −21,773 | $7.65 | −$166,563.45 | 398,751 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.